![square logo](/sites/us2country/files/2024-01/Logo%20%281%29%20%282%29.jpg)
UpCard®-CA1 (torsemide oral solution) is Now Available
July 2024
![square logo](/sites/us2country/files/2024-01/Logo%20%281%29%20%282%29.jpg)
UpCard®-CA1 (torsemide oral solution) from Vetoquinol Receives Conditional Approval
May 2024
![NexHA Logo Square](/sites/us2country/files/2024-03/NexHA-logo-black-web%20%282%29.png)
NexHA™ (hyaluronate sodium) Injectable Solution returns to market
March 2024
![square logo](/sites/us2country/files/2024-01/Logo%20%281%29%20%282%29.jpg)
Fortune Media and Great Place To Work Name Vetoquinol USA to 2023 Fortune Best Workplaces in Texas
January 2024
November 2023
![VetPowerment](/sites/us2country/files/2023-05/news-vetpowerment.png)
Vetoquinol Launches VetPowerment™ Employee Engagement Tool
March 2023
![Flexadin 4 Life](/sites/us2country/files/2023-05/news-flexadin-4-life.png)
Vetoquinol Announces 5 New Flexadin® Products
October 2022
![Simplera carton and blister pack](/sites/us2country/files/2023-05/news-simplera.jpg)
Vetoquinol Launches Simplera® (florfenicol, terbinafine, mometasone furoate) Otic Solution for Dogs
September 2022
![Humane Society of North Texas](/sites/us2country/files/2023-05/news-hsnt.png)
Vetoquinol Launches Rehabilitation Business Solution Service
July 2022